XML 22 R28.htm IDEA: XBRL DOCUMENT v3.2.0.727
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Feb. 02, 2015
Dec. 31, 2014
Dec. 09, 2014
Nov. 05, 2014
Apr. 30, 2014
Mar. 31, 2014
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
Dec. 16, 2014
Apr. 17, 2014
Mar. 18, 2014
Common stock, price per share at closing dates                     $ 0.0348 $ 0.04
Common stock fixed price per share             $ 0.0033          
Preferred stock deemed dividend value         $ 1,673,127 $ 8,376,719            
Amortization of deemed dividend value of preferred stock               $ 1,209,970        
Voting equity securities on preferred stock            

designated as 9% Cumulative Convertible Preferred Stock (non-voting, “9% Preferred Stock”)

          
Percentage of convertible notes payable   10.00%         10.00%   10.00%      
Convertible into common stock fixed price per share             $ 0.035   $ 0.035      
Debt instrument due date Sep. 15, 2015 Sep. 15, 2015 Sep. 15, 2015 Sep. 15, 2015     Sep. 15, 2015          
Fair value of convertible notes, percentage             52.00%          
Fair value of warrants, percentage             48.00%          
Fair value of beneficial conversion feature value             $ (83,320)          
Stock options granted             500,000 4,300,000        
Stock options exercised                        
Percentage of ownership             50.00%          
Grant Revenues             $ 74,534          
Grant receivable   $ 48,000         28,583   $ 48,000      
Unearned grant revenue             $ 34,333 $ 12,382        
Comprehensive income (loss)                        
Equipment [Member] | Minimum [Member]                        
Furniture and equipment, estimated useful lives             3 years          
Equipment [Member] | Maximum [Member]                        
Furniture and equipment, estimated useful lives             5 years          
Closing Market Price [Member]                        
Closing market prices $ 0.043   $ 0.0411 $ 0.0524     $ 0.0451          
Series G 1.5% Convertible Preferred Stock [Member]                        
Convertible preferred stock, per share             $ 0.323705     $ 0.68888    
Deemed dividend on lippa's investment               2,780,303        
Proceeds from issuance of private placements             $ 443,848          
10% Convertible Notes Payable [Member]                        
Proceeds from issuance of private placements               85,000        
10% Convertible Notes Payable [Member]                        
Proceeds from issuance of private placements $ 210,000   $ 46,000                  
Warrant Purchase Agreement [Member] | Various Accredited Investors [Member]                        
Percentage of convertible notes payable       10.00%                
Proceeds from issuance       $ 238,500                
Debt instrument due date       Sep. 15, 2015                
Closing market prices       $ 0.035                
Chairman and Chief Executive Officer [Member]                        
Preferred stock purchased             $ 250,000          
Preferred stock purchased, shares             250          
Percentage of shares held on sale             33.20%          
Percentage of purchase of convertible preferred stock             26.90%          
Voting equity securities on preferred stock            

Dr. Lippa did not control, directly or indirectly, 10% or more of the Company’s voting equity securities at the time of his investment.

          
Deemed dividend on lippa's investment               $ 1,209,970        
Series G 1.5% Convertible Preferred Stock [Member]                        
Convertible preferred stock issued                     175.28 753.22
Convertible preferred stock, per share                       $ 1,000
Warrants [Member]                        
Closing market prices             $ 0.035          
Fair value of warrants             $ 176,549          
Fair value of beneficial conversion feature value             $ 192,951